FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183453989> ?p ?o ?g. }

• W3183453989 endingPage "1661" @default.
• W3183453989 startingPage "1656" @default.
• W3183453989 abstract "To evaluate the effectiveness, treatment patterns and long-term safety of ranibizumab 0.5 mg in treatment-naïve patients with central retinal vein occlusion (CRVO) in a real-world setting.LUMINOUS, a 5-year, global, prospective, multicentre, multi-indication, observational, open-label study, recruited treatment naïve or prior treated patients who were treated as per the local ranibizumab label. Here, we report the mean change in visual acuity (VA; Early Treatment Diabetic Retinopathy Study [ETDRS] letters), treatment exposure over year (Y) 1 and 5-year safety in treatment-naïve CRVO patients.At baseline, the mean age of treatment-naïve CRVO patients (n = 327) was 68.9 years, with a mean (Standard deviation [SD]) VA of 40.6 (23.9) letters. At Y1, patients (n = 144) had a mean (SD) VA gain from baseline of 10.8 (19.66) letters, with a mean (SD) of 5.4 (2.65) ranibizumab injections. Patients demonstrated mean (SD) VA gains of 2.7 (19.35), 11.6 (20.56), 13.9 (18.08), 11.1 (18.46) and 8.2 (24.86) letters with 1, 2-3, 4-5, 6-8 and >8 ranibizumab injections, respectively. Mean (SD) VA gains at Y1 in patients receiving loading (67.4%) and no loading dose (32.6%) was 11.9 (20.42) and 8.4 (17.99) letters, respectively. Over five years, the incidence of ocular/non-ocular adverse events (AEs) and serious AEs was 11.3%/8.6% and 1.2%/6.7%, respectively.These results demonstrate the effectiveness of ranibizumab in treatment-naïve CRVO patients at Y1 with clinically meaningful VA gains and no new safety findings over five years. These findings may help inform routine practice and enable better clinical management to achieve optimal visual outcomes." @default.
• W3183453989 created "2021-08-02" @default.
• W3183453989 creator A5004278954 @default.
• W3183453989 creator A5019355371 @default.
• W3183453989 creator A5027716150 @default.
• W3183453989 creator A5037985769 @default.
• W3183453989 creator A5050404936 @default.
• W3183453989 creator A5059444413 @default.
• W3183453989 creator A5069429479 @default.
• W3183453989 creator A5072541133 @default.
• W3183453989 creator A5083564913 @default.
• W3183453989 date "2021-07-29" @default.
• W3183453989 modified "2023-10-14" @default.
• W3183453989 title "Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study" @default.
• W3183453989 cites W1782108791 @default.
• W3183453989 cites W1973608834 @default.
• W3183453989 cites W1978704499 @default.
• W3183453989 cites W1989515430 @default.
• W3183453989 cites W1994687820 @default.
• W3183453989 cites W2008299291 @default.
• W3183453989 cites W2024615783 @default.
• W3183453989 cites W2034477424 @default.
• W3183453989 cites W2038364050 @default.
• W3183453989 cites W2052204551 @default.
• W3183453989 cites W2073559780 @default.
• W3183453989 cites W2074654625 @default.
• W3183453989 cites W2091729420 @default.
• W3183453989 cites W2107443927 @default.
• W3183453989 cites W2123232376 @default.
• W3183453989 cites W2128701654 @default.
• W3183453989 cites W2129223002 @default.
• W3183453989 cites W2141855743 @default.
• W3183453989 cites W2144771657 @default.
• W3183453989 cites W2285674438 @default.
• W3183453989 cites W2558856677 @default.
• W3183453989 cites W2574437654 @default.
• W3183453989 cites W2594194750 @default.
• W3183453989 cites W2694800465 @default.
• W3183453989 cites W2766287528 @default.
• W3183453989 cites W2770650418 @default.
• W3183453989 cites W2895748115 @default.
• W3183453989 cites W2964773243 @default.
• W3183453989 cites W2989019570 @default.
• W3183453989 cites W2990343807 @default.
• W3183453989 cites W3001049181 @default.
• W3183453989 cites W3030682574 @default.
• W3183453989 cites W3136227362 @default.
• W3183453989 doi "https://doi.org/10.1038/s41433-021-01702-y" @default.
• W3183453989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34326500" @default.
• W3183453989 hasPublicationYear "2021" @default.
• W3183453989 type Work @default.
• W3183453989 sameAs 3183453989 @default.
• W3183453989 citedByCount "4" @default.
• W3183453989 countsByYear W31834539892022 @default.
• W3183453989 countsByYear W31834539892023 @default.
• W3183453989 crossrefType "journal-article" @default.
• W3183453989 hasAuthorship W3183453989A5004278954 @default.
• W3183453989 hasAuthorship W3183453989A5019355371 @default.
• W3183453989 hasAuthorship W3183453989A5027716150 @default.
• W3183453989 hasAuthorship W3183453989A5037985769 @default.
• W3183453989 hasAuthorship W3183453989A5050404936 @default.
• W3183453989 hasAuthorship W3183453989A5059444413 @default.
• W3183453989 hasAuthorship W3183453989A5069429479 @default.
• W3183453989 hasAuthorship W3183453989A5072541133 @default.
• W3183453989 hasAuthorship W3183453989A5083564913 @default.
• W3183453989 hasBestOaLocation W31834539891 @default.
• W3183453989 hasConcept C118487528 @default.
• W3183453989 hasConcept C120665830 @default.
• W3183453989 hasConcept C121332964 @default.
• W3183453989 hasConcept C126322002 @default.
• W3183453989 hasConcept C134018914 @default.
• W3183453989 hasConcept C141071460 @default.
• W3183453989 hasConcept C197934379 @default.
• W3183453989 hasConcept C2776694085 @default.
• W3183453989 hasConcept C2777802072 @default.
• W3183453989 hasConcept C2778257484 @default.
• W3183453989 hasConcept C2778844676 @default.
• W3183453989 hasConcept C2779829184 @default.
• W3183453989 hasConcept C2780347916 @default.
• W3183453989 hasConcept C2781100027 @default.
• W3183453989 hasConcept C555293320 @default.
• W3183453989 hasConcept C61511704 @default.
• W3183453989 hasConcept C71924100 @default.
• W3183453989 hasConceptScore W3183453989C118487528 @default.
• W3183453989 hasConceptScore W3183453989C120665830 @default.
• W3183453989 hasConceptScore W3183453989C121332964 @default.
• W3183453989 hasConceptScore W3183453989C126322002 @default.
• W3183453989 hasConceptScore W3183453989C134018914 @default.
• W3183453989 hasConceptScore W3183453989C141071460 @default.
• W3183453989 hasConceptScore W3183453989C197934379 @default.
• W3183453989 hasConceptScore W3183453989C2776694085 @default.
• W3183453989 hasConceptScore W3183453989C2777802072 @default.
• W3183453989 hasConceptScore W3183453989C2778257484 @default.
• W3183453989 hasConceptScore W3183453989C2778844676 @default.
• W3183453989 hasConceptScore W3183453989C2779829184 @default.
• W3183453989 hasConceptScore W3183453989C2780347916 @default.
• W3183453989 hasConceptScore W3183453989C2781100027 @default.
• W3183453989 hasConceptScore W3183453989C555293320 @default.

• next